Discover
ELEV
Elevation Oncology, Inc.
0.36
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | ||
| 1y |
0.36
day range
0.36
0.44
52 week range
5.83
| Open | 0.37 | Prev Close | 0.36 | Low | 0.36 | High | 0.36 | Mkt Cap | 33.90M |
| Vol | 4.38M | Avg Vol | 773.88K | EPS | -0.80 | P/E | N/A | Forward P/E | -0.63 |
| Beta | 1.25 | Short Ratio | 9.52 | Inst. Own | 83.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.60 | 200-d Avg | 2.17 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 14.22M | ||
| Research and Development Expense | 6.88M | ||
| Selling, General and Administrative Expense | 3.97M | ||
| Operating Income | -14.22M | ||
| Income Tax Expense | 6.00K | ||
| Net Income | -14.21M | ||
| Net Income Common Stock | -14.21M | ||
| Net Income Common Stock (USD) | -14.21M | ||
| Consolidated Income | -14.21M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -14.20M | ||
| Earning Before Interest & Taxes (USD) | -14.20M | ||
| Weighted Average Shares | 59.17M | ||
| Weighted Average Shares Diluted | 59.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 60.49M | ||
| Cash and Equivalents (USD) | 60.49M | ||
| Investments | 20.17M | ||
| Investments Current | 20.17M | ||
| Current Assets | 82.19M | ||
| Property, Plant & Equipment Net | 29.00K | ||
| Total Assets | 82.22M | ||
| Total Debt | 31.25M | ||
| Current Liabilities | 4.24M | ||
| Debt Non-Current | 31.25M | ||
| Total Liabilities | 35.49M | ||
| Accumulated Retained Earnings (Deficit) | -254.67M | ||
| Accumulated Other Comprehensive Income | 11.00K | ||
| Shareholders Equity | 46.73M | ||
| Shareholders Equity (USD) | 46.73M | ||
| Assets Non-Current | 29.00K | ||
| Total Debt (USD) | 31.25M | ||
| Liabilities Non-Current | 31.25M | ||
| Trade and Non-Trade Payables | 492.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.00K | ||
| Net Cash Flow from Financing | -17.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 11.03M | ||
| Issuance (Purchase) of Equity Shares | -17.00K | ||
| Net Cash Flow from Investing | 23.76M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 23.76M | ||
| Net Cash Flow from Operations | -12.71M | ||
| Share Based Compensation | 987.00K | ||